MYOCARDIAL INFARCTION
Clinical trials for MYOCARDIAL INFARCTION explained in plain language.
Never miss a new study
Get alerted when new MYOCARDIAL INFARCTION trials appear
Sign up with your email to follow new studies for MYOCARDIAL INFARCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart drug delivery method tested in 150 patients
Disease control TerminatedThis study looked at whether giving the blood thinner abciximab directly into the heart artery works as well as giving it through a vein followed by a 12-hour drip. The goal was to reduce heart muscle damage in people having a first non-ST elevation heart attack. The study was st…
Matched conditions: MYOCARDIAL INFARCTION
Phase: PHASE4 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated May 17, 2026 04:35 UTC
-
Heart attack drug trial halted: did BI 765845 fail?
Disease control TerminatedThis study tested a medicine called BI 765845 in adults who recently had a heart attack. The goal was to see if it could reduce heart muscle damage compared to a placebo. Participants received either the drug or a placebo infusion, and heart health was monitored for 3 months. The…
Matched conditions: MYOCARDIAL INFARCTION
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New CT scan could replace risky tests for late heart attack patients
Diagnosis TerminatedThis study looked at whether a special CT scan (dual-energy cardiac CT) can check heart muscle damage as well as an MRI in people who had a heart attack more than 24 hours earlier. The goal was to see if the CT scan could give doctors enough information to decide on treatment, av…
Matched conditions: MYOCARDIAL INFARCTION
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Diagnosis
Last updated May 11, 2026 20:48 UTC